Role of the Gut Microbiome in the Pathogenesis of Obesity and Obesity-Related Metabolic Dysfunction von Bouter, Kristien E, van Raalte, Daniël H, Groen, Albert K, Nieuwdorp, Max

Volltext

Safety of Semaglutide von Smits, Mark M, Van Raalte, Daniël H

Volltext

Gut Microbiota as a Trigger for Metabolic Inflammation in Obesity and Type 2 Diabetes von Scheithauer, Torsten P M, Rampanelli, Elena, Nieuwdorp, Max, Vallance, Bruce A, Verchere, C Bruce, van Raalte, Daniël H, Herrema, Hilde

Volltext

Glomerular Hyperfiltration in Diabetes: Mechanisms, Clinical Significance, and Treatment von Tonneijck, Lennart, Muskiet, Marcel H A, Smits, Mark M, van Bommel, Erik J, Heerspink, Hiddo J L, van Raalte, Daniël H, Joles, Jaap A

Volltext

The role of renal hypoxia in the pathogenesis of diabetic kidney disease: a promising target for newer renoprotective agents including SGLT2 inhibitors? von Hesp, Anne C., Schaub, Jennifer A., Prasad, Pottumarthi V., Vallon, Volker, Laverman, Gozewijn D., Bjornstad, Petter, van Raalte, Daniël H.

Volltext

Cardiovascular effects of glucagon-like peptide 1 receptor agonists: from mechanistic studies in humans to clinical outcomes von Heuvelman, Valerie D, Van Raalte, Daniël H, Smits, Mark M

Volltext

GLP-1 and the kidney: from physiology to pharmacology and outcomes in diabetes von Muskiet, Marcel H. A., Tonneijck, Lennart, Smits, Mark M., van Baar, Michaël J.B., Kramer, Mark H. H., Hoorn, Ewout J., Joles, Jaap A., van Raalte, Daniël H.

Volltext

SGLT2 Inhibitors in Combination Therapy: From Mechanisms to Clinical Considerations in Type 2 Diabetes Management von van Baar, Michaël J B, van Ruiten, Charlotte C, Muskiet, Marcel H A, van Bloemendaal, Liselotte, IJzerman, Richard G, van Raalte, Daniël H

Volltext

Lixisenatide and renal outcomes in patients with type 2 diabetes and acute coronary syndrome: an exploratory analysis of the ELIXA randomised, placebo-controlled trial von Muskiet, Marcel H A, Tonneijck, Lennart, Huang, Yao, Liu, Minzhi, Saremi, Aramesh, Heerspink, Hiddo J L, van Raalte, Daniël H

Volltext

The renal hemodynamic effects of the SGLT2 inhibitor dapagliflozin are caused by post-glomerular vasodilatation rather than pre-glomerular vasoconstriction in metformin-treated pat... von van Bommel, Erik J.M., Muskiet, Marcel H.A., van Baar, Michaël J.B., Tonneijck, Lennart, Smits, Mark M., Emanuel, Anna L., Bozovic, Andrea, Danser, A.H. Jan, Geurts, Frank, Hoorn, Ewout J., Touw, Daan J., Larsen, Emil L., Poulsen, Henrik E., Kramer, Mark H.H., Nieuwdorp, Max, Joles, Jaap A., van Raalte, Daniël H.

Volltext

Improving glycaemic control in type 2 diabetes: Stimulate insulin secretion or provide beta‐cell rest? von van Raalte, Daniël H., Verchere, C. Bruce

Volltext

Comment on Bezin et al. GLP-1 Receptor Agonists and the Risk of Thyroid Cancer. Diabetes Care 2023;46:384-390 von Smits, Mark M, van Raalte, Daniël H

Volltext

Age Ain't Nothing But a Number . . . or Is It? von Redondo, Maria J, van Raalte, Daniël H

Volltext

Causality of small and large intestinal microbiota in weight regulation and insulin resistance von Scheithauer, Torsten P.M, Dallinga-Thie, Geesje M, de Vos, Willem M, Nieuwdorp, Max, van Raalte, Daniël H

Volltext

Nephroprotective effects of GLP-1 receptor agonists: where do we stand? von Mosterd, Charlotte M., Bjornstad, Petter, van Raalte, Daniël H.

Volltext

Role of sodium-glucose cotransporter 2 inhibition to mitigate diabetic kidney disease risk in type 1 diabetes von van Raalte, Daniël H, Bjornstad, Petter

Volltext

Oral butyrate does not affect innate immunity and islet autoimmunity in individuals with longstanding type 1 diabetes: a randomised controlled trial von de Groot, Pieter F., Nikolic, Tatjana, Imangaliyev, Sultan, Bekkering, Siroon, Duinkerken, Gaby, Keij, Fleur M., Herrema, Hilde, Winkelmeijer, Maaike, Kroon, Jeffrey, Levin, Evgeni, Hutten, Barbara, Kemper, Elles M., Simsek, Suat, Levels, Johannes H. M., van Hoorn, Flora A., Bindraban, Renuka, Berkvens, Alicia, Dallinga-Thie, Geesje M., Davids, Mark, Holleman, Frits, Hoekstra, Joost B. L., Stroes, Erik S. G., Netea, Mihai, van Raalte, Daniël H., Roep, Bart O., Nieuwdorp, Max

Volltext

Natriuretic Effect of Two Weeks of Dapagliflozin Treatment in Patients With Type 2 Diabetes and Preserved Kidney Function During Standardized Sodium Intake: Results of the DAPASALT... von Scholtes, Rosalie A, Muskiet, Marcel H A, van Baar, Michiel J B, Hesp, Anne C, Greasley, Peter J, Karlsson, Cecilia, Hammarstedt, Ann, Arya, Niki, van Raalte, Daniël H, Heerspink, Hiddo J L

Volltext

Sodium glucose cotransporter 2 inhibition and renal ischemia: implications for future clinical trials von van Raalte, Daniël H., Cherney, David Z.I.

Volltext

Distinct fecal and oral microbiota composition in human type 1 diabetes, an observational study von de Groot, Pieter F, Belzer, Clara, Aydin, Ömrüm, Levin, Evgeni, Levels, Johannes H, Aalvink, Steven, Boot, Fransje, Holleman, Frits, van Raalte, Daniël H, Scheithauer, Torsten P, Simsek, Suat, Schaap, Frank G, Olde Damink, Steven W M, Roep, Bart O, Hoekstra, Joost B, de Vos, Willem M, Nieuwdorp, Max

Volltext